Home LiteratureArticle Details
PMID: 16998887 Published · ppublish English Journal Article Research Support, N.I.H., Extramural

Serum antibody decay in adults following natural respiratory syncytial virus infection.

Journal of medical virology ·Vol. 78 ·No. 11 ·2006-11-00 ·Pages 1493-7

Falsey AR, Singh HK, Walsh EE

Abstract

Serum antibody decay following RSV infection in adults was examined to evaluate the durability of the immune response. Twenty subjects with RSV infection and 10 subjects who remained RSV uninfected had blood samples obtained over 16-25 months analyzed by microneutralization assay and enzyme immunoassay. The mean titers of infected subjects rose approximately eightfold post-infection. The mean rate of antibody decline was -0.20 log 2 titer per month which led to a > or =fourfold drop in titer in 75% of subjects at 1 year. In contrast, titers of uninfected subjects were relatively stable. The partial immunity resulting from a boost in serum antibody following natural RSV infection in adults appears to be short lived.

MeSH Terms
Adult Aged Antibodies, Viral/blood Humans Respiratory Syncytial Virus Infections/immunology Time Factors
Chemicals
Antibodies, Viral
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Falsey Ann R
Department of Medicine at Rochester General Hospital, Department of Medicine, University of Rochester School of Medicine and Dentistry, Rochester, New York 14621, USA. ann.falsey@viahealth.org
Singh Harjot K
Walsh Edward E
Article Info
Journal
Journal of medical virology
Abbr.
J Med Virol
ISSN
0146-6615
Published
2006-11-00
Pages
1493-7
Language
English
Region
United States
NLM ID
7705876
Subset
IM
Grants
NIAID NIH HHS · R01-AI-45969 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com